Pharmacometric dose optimization of buprenorphine in neonatal opioid withdrawal syndrome
Abstract Results from Blinded Buprenorphine OR Neonatal morphine solution (BBORN), a previous phase III trial in infants with neonatal opioid withdrawal syndrome (NOWS), demonstrated that sublingual buprenorphine resulted in a shorter duration of treatment and shorter length of hospital stay than th...
Saved in:
Main Authors: | Rena Eudy‐Byrne (Author), Nicole Zane (Author), Susan C. Adeniyi‐Jones (Author), Marc R. Gastonguay (Author), Ana Ruiz‐Garcia (Author), Gagan Kaushal (Author), Walter K. Kraft (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
by: Niraj R. Chavan, et al.
Published: (2017) -
Buprenorphine therapy in the setting of induced opioid withdrawal from oral naltrexone: a case report
by: Laura M. Szczesniak, et al.
Published: (2020) -
Comparing methadone and buprenorphine maintenance with methadone-assisted withdrawal for the treatment of opioid dependence during pregnancy: maternal and neonatal outcomes
by: Lund IO, et al.
Published: (2012) -
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
by: Celine M. Laffont, et al.
Published: (2022) -
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
by: Rahimah Hassan, et al.
Published: (2021)